Jasper Therapeutics Inc (NASDAQ: JSPR) started the day on Wednesday, with a price increase of 7.89% at $2.05, before settling in for the price of $1.9 at the close. Taking a more long-term approach, JSPR posted a 52-week range of $1.39-$21.27.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 54.53%. Meanwhile, its Annual Earning per share during the time was 54.53%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 14.93%. This publicly-traded company’s shares outstanding now amounts to $27.98 million, simultaneously with a float of $23.87 million. The organization now has a market capitalization sitting at $57.37 million. At the time of writing, stock’s 50-day Moving Average stood at $1.8400, while the 200-day Moving Average is $3.3200.
Jasper Therapeutics Inc (JSPR) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Jasper Therapeutics Inc’s current insider ownership accounts for 14.71%, in contrast to 59.97% institutional ownership. According to the most recent insider trade that took place on Sep 22 ’25, this organization’s Director bought 41,000 shares at the rate of 2.43, making the entire transaction reach 99,630 in total value, affecting insider ownership by 41,000. Preceding that transaction, on Sep 22 ’25, Company’s Director bought 20,000 for 2.43, making the whole transaction’s value amount to 48,600. This particular insider is now the holder of 20,000 in total.
Jasper Therapeutics Inc (JSPR) Earnings and Revenue Records
Jasper Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 14.93% and is forecasted to reach -2.36 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 28.27% through the next 5 years, which can be compared against the 54.53% growth it accomplished over the previous five years trading on the market.
Jasper Therapeutics Inc (NASDAQ: JSPR) Trading Performance Indicators
Let’s observe the current performance indicators for Jasper Therapeutics Inc (JSPR). It’s Quick Ratio in the last reported quarter now stands at 2.59.
In the same vein, JSPR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.90, a figure that is expected to reach -0.67 in the next quarter, and analysts are predicting that it will be -2.36 at the market close of one year from today.
Technical Analysis of Jasper Therapeutics Inc (JSPR)
If we take a close look at the recent performances of Jasper Therapeutics Inc (NASDAQ: JSPR), its last 5-days Average volume was 0.48 million that shows plunge from its year to date volume of 0.48 million. During the previous 9 days, stock’s Stochastic %D was recorded 77.86% While, its Average True Range was 71.89.
Raw Stochastic average of Jasper Therapeutics Inc (JSPR) in the period of the previous 100 days is set at 37.71%, which indicates a major fall in contrast to 95.12% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1100 that was lower than 0.1600 volatility it exhibited in the past 100-days period.
